Acute Lymphocytic Leukemia (ALL) Completed Phase 2 Trials for Mycophenolate mofetil (DB00688)

Back to Acute Lymphocytic Leukemia (ALL)

Also known as: Lymphocytic Leukemia, Acute / Acute Lymphocytic Leukemia / Acute Lymphoid Leukemia (ALL) / Acute Lymphatic Leukemia / Acute Lymphocytic Leukaemia / Acute Lymphoid Leukemia / Acute lymphoblastic leukemia with failed remission / Acute lymphoblastic leukaemia / Leukemia lymphoblastic acute / Acute lymphoblastic leukemia / Lymphoid leukaemia, acute / Acute lymphoid leukaemia / Lymphoid leukemia, acute / ALL / Leukaemia lymphoblastic acute / Acute lymphatic leukaemia / Leukaemias acute lymphocytic

Indication	Status	Phase
DBCOND0030518 (Acute Lymphocytic Leukemia (ALL))	Completed	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT02294552	Post-transplantation Cyclophosphamide as GVHD Prophylaxis After HSCT	Treatment	Busulfan (DB01008) Cyclophosphamide (DB00531) Fludarabine (DB01073) Mycophenolate mofetil (DB00688) Tacrolimus (DB00864)
NCT00571662	Safety and Efficacy of Pentostatin and Low Dose TBI With Allogenic Peripheral Blood Stem Cell Transplant	Treatment	Ciclosporin (DB00091) Mycophenolate mofetil (DB00688) Pentostatin (DB00552) Sargramostim (DB00020)
NCT01350245	Bone Marrow Transplantation of Patients in Remission Using Partially Matched Relative Donor	Treatment	Cyclophosphamide (DB00531) Mycophenolate mofetil (DB00688) Tacrolimus (DB00864)